chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient came in to get second dose of Covid19 vaccine. She did not have her vaccination card and wanted us to look up what she had. technician looked up and saw she had Moderna covid19 vaccine but proceeded to label the patient's consent form with Pfizer Covid 19 vaccine label. Pharmacist verified with patient before injecting and she confirmed pfizer thinking that the technician had properly looked up and labeled her consent form. She was administered one dose of Pfizer today instead of Moderna. Verified on the CDC website that patient can receive one of each of the mRNA vaccines as long as they're minimum 28 days apart. Patient does not need to finish series of either vaccines. she is sufficiently protected at this time with one dose of moderna and one dose of pfizer.
I have had tinnitus for Many Years . It has always been at a low level and did not bother me.  approximately 3-4 days after I took the Moderna Vaccine by tinnitus became intolerable . there were nights that I had difficulty sleeping .  Some days it would spike more than others . I took the second dose and it did not a make the spikes more or less.  The only other times I had such annoying spikes were when I took Doxycycline and Zithromax .  Spikes after doxycycline - which was severe - disappeared as soon as I stopped taking it  The Zithromax    spike took 2 months to settle down
Symptoms started with mild aches then had fever which reached 100. This lasted until the next day. My arm was sore and swollen. My arm was sore for a few days and eventually had a nasty bruise. Experienced similar symptoms with the booster which I received on Aug. 6th, 2018.
Overnight on Friday October 8, a fast-spreading rash appeared on my chest, neck and stomach. I went to an urgent care on Saturday morning and they stated that the new rash (outside of the hives from the deodorant) was fungal. They gave me a prescription to take care of it and OTC anti-fungal cream. From Saturday to Sunday, the rash spread to be all over my upper body. I called my primary care doctor and was able to speak on the phone to their on-call doctor for non-work hours. They suggested that since it was fast spreading, I go to different urgent care and schedule an appointment with my primary on Monday. The second urgent care on Sunday stated it was an allergic reaction and gave me one shot of benadryl and one shot of cortisone which helped minimize the rash. On Monday, the nurse practitioner confirmed it was an allergic reaction and provided a 9-day prescription of steroid pills. I have finished the steroid pills and the rash is now gone.
I developed Synovus in my right knee resulting in pain, swelling and fluid in and around my knee. Surgery was required to adress the problem. .
After my second dose of the Moderna vaccine, I experienced extreme facial swelling the following morning (03/31/21). The next day, I experienced numbness and tingling  in my right leg that lasted 10+ hours. I received my booster shot (03/10/22) and starting that night and every single day since receiving it, I have broken out in large patches of extremely itchy hives on my neck, chest, stomach, groin, backs of my knees, back, shoulders,  and my hands and feet.
Started period the day after shot but expecting one anyways but then on 9/16 period started again and was very heavy for two days. This period was very heavy and short, not like usual periods. Much more cramping and some nausea.
Patient has negative titers to the Mumps, Rubella and Varicella.; Patient has negative titers to the Mumps, Rubella and Varicella; Patient has negative titers to the Mumps, Rubella and Varicella; This spontaneous report was received from nurse practioner referring to an 18-year-old female. The patient's pertinent medical history included scoliosis. The patient was not taking any concomitant medications. The patient did not have any drug allergies and reactions.   On 10-JAN-2006, the patient vaccinated with first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) for prophylaxis (lot number, expiration date, and route of administration, dose, vaccination scheme, and anatomical location of vaccination were not reported) and first dose of varicella virus vaccine live (oka/merck) (VARIVAX), (lot number, expiration date, and route of administration, dose, vaccination scheme, and anatomical location of vaccination were not reported) for prophylaxis.   On 03-DEC-2007, the patient vaccinated with second dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) for prophylaxis (lot number, expiration date, and route of administration, dose, vaccination scheme, and anatomical location of vaccination were not reported) and second dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot number, expiration date, and route of administration, dose, vaccination scheme, and anatomical location of vaccination were not reported) administered for prophylaxis.   On 25-FEB-2022, the patient had negative titers to the Mumps, Rubella, and Varicella. the reporter stated that she received two doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and two doses of varicella virus vaccine live (oka/merck) (VARIVAX) in the past. the patient was not given treatment for the negative titers to the Mumps, Rubella and Varicella.  At the time of reporting, the outcome of mumps antibody test negative, varicella virus test negative and rubella antibody negative was unknown.        The causal relationship between mumps antibody test negative, varicella virus test negative and rubella antibody negative and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and varicella virus vaccine live (oka/merck) (VARIVAX) was not provided.
3/15- 16 - tightness across upper back/shoulders into upper arms in the morning, rested and took naproxen 3/19 - major symptoms, tightness across upper back/shoulders, tightness/pain across chest, extreme fatigue. This happened while grocery shopping mid-morning.  Wondered if it was a mild heart attack. Nearly abandoned shopping cart, but checked out, went home and rested for several hours. 3/23-24 - woke up with similar symptoms as 3/19, though not as bad on 3/23, but worse on 3/24. Rested on 3/24 until appt with Primary Doctor.
Full body convulsions, completely locking up the body, eased over time. Fever. Nausea. Extreme muscle weakness and headaches.
11:50 am- Hepatitis A (dose #1) administered to right deltoid IM (0.5 mL). Pt became slightly diaphoretic and fainted. Pt. lowered to floor and Became being awake-Alert w/in approx 8 seconds. Given juice and cookies given. Pt was extremely anxious at home and administered. (Had been hyperventilating)
headache; body aches; hurts to eat and chew food.; This is a spontaneous report received from a contactable consumer or other non hcp via Pfizer. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number was not reported) via an unspecified route of administration on an unspecified date as single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The reporter called on behalf of mother who had 1st Pfizer vaccine last week. The patient experienced headache, body aches, hurts to eat and chew food on an unspecified date. Outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Pt. complained of sore arm from the flu shot and had 2 red spots. Spoke with her on 01/17/2002 and the symptoms were resolved.
Reaction: Dizziness (not initially reported), heavy chest (similar to when she has had arrhythmias in the past) and racing heart  Outcomes: Patient brought to floor with feet elevated. Vitals taken and O2 given. Symptoms resolved while supine, but patient continued to be dizzy when she was sat up. Transported to ED and symptoms resolved.
Sore arm, limited range of motion. Went to MD, thinks it was placed in wrong position, caused tendonitis. Taking ALEVE and is improving.
Red and swollen at injection site. Lymph nodes swollen and tender. Addendum- seen by PCM 3/4/04- with Left arm erythema, swelling, cm-enlarged left axilla lymph node-give pt meds-Benadryl-sent to immunization.
03/23/21 - 03/26/21: arm soreness, headache, fatigue 04/05/21: singular, mid-forehead rash began to appear 04/06/21: forehead rash began to swell, scalp tenderness, forehead pain and some itchiness, headache, brain fog 04/12/21: symptoms progress + facial swelling; diagnosed as impetigo; completed course of Keflex and prednisone taper 04/21/21, mupirocin (on-going); facial swelling resolved, but other symptoms persist 4/28/21: diagnosed as shingles; started Valtrex, acyclovir oint and higher dose prednisone taper x10 days, mupirocin on-going 05/06/21: right foot pain/ankle swelling and bruising after extremely mild walking (old injury to same ankle but never any problems)  05/12/21 and 07/28/21: rash resembling forehead rash appear on front/back of elbows with mild joint pain and stiffness
35 patints exposed to vaccine from which vial may have been punctured more than 20 times; This spontaneous case was reported by another health care professional and describes the occurrence of PRODUCT ADMINISTRATION ERROR (35 patints exposed to vaccine from which vial may have been punctured more than 20 times) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Nov-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (35 patints exposed to vaccine from which vial may have been punctured more than 20 times). On 04-Nov-2021, PRODUCT ADMINISTRATION ERROR (35 patints exposed to vaccine from which vial may have been punctured more than 20 times) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant drugs were reported. No treatment drugs were reported. Patient date of birth was 1968.
Right after immunizations secretion increased; next day mild retractions, nasal flaring, coughing with increase secretions calmer with aerosol tx's secretions the next night also with coughing and discomfort, low grade temp 99.1 F (Tylenol and Motrin) given alternating thru night. 06/27 wheezing, nasal flaring and retracting not relieved by in-line ventilator. Brought to ER. Per ER Xopenex 126mg x 2 given and other ER measures. Tachypnea, atelectasis, pulmonary congestion.
Systemic: Nausea-Mild, Systemic: itching at injection site, high blood pressure around 160 but dropped; symptoms lasted 0 days
Six days after receiving SHINGRIX patient experienced weakness in the legs followed by a fall at home. Weakness progressed and he was unable to use his legs. He was transferred to the hospital by ambulance and subsequently transferred to Neurology where he was diagnosed with Guillain-Barre syndrome. They attempted a lumbar puncture when he was flexed. He developed severe respiratory failure and had to be intubated. With a tach and ventilator he was in the ICU for 3 weeks. He was discharged to a skilled nursing facility and now he is home walking with a walker.
This spontaneous report has been received from a pharmacist referring to a patient of unknown age. On 02-DEC-2015 the patient was vaccinated with improperly stored M-M-R II (dose and route not reported, lot # L012479, expiration date: 10-APR-2017). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
This case was reported by a health professional on 03 October 2007. Seriousness criteria:Other-Medically Significant A female received a DTaP vaccination (manufacturer and lot number unknown) "when she was younger" and experienced an anaphylactic reaction. She recovered, and has since received other vaccines "without any problems". No additional information was provided.
Fever, Diarrhea, NauseaVomiting, RIGORS, FATIGUE, MILD INJECTIO SITE ARM PAIN Narrative:
The patient was given Pfizer monovalent vaccine for ages 5years to 11 years instead of Pfizer monovalent vaccine for ages 12 years and older.
Red, hot, raised area on left arm encompassing injection site.  First noticed evening of 1/15/21.  Topical hydrocortisone applied BID, Benedryl 50 mg PO taken on  January 15, 16 and 17.  Today, 1/18, site is noticeably less red, no longer raised or  hot.  While the area is not completely resolved, it is much better.  I indicated that I have not recovered as it is not totally resolved.
On day 86 I woke up and had severe vertigo and had lost the hearing in my right ear. I have been in physical therapy for a few weeks. The hearing has returned to a minimal extent but it's better than it was on June 12, 2021. The physical therapist recommended I report the lost hearing because it has been noted as a possible side effect for some people. The hearing specialist said the nerve between the middle ear and brain is no longer working and the hearing loss is likely permanent.
itched around the site of the injection after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itched around the site of the injection after the first dose) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-May-2021, the patient experienced VACCINATION SITE PRURITUS (itched around the site of the injection after the first dose). At the time of the report, VACCINATION SITE PRURITUS (itched around the site of the injection after the first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.  No concomitant medications were reported.
second dose administered was stronger(0.7); High Fever (102); Achy; hard to stand up; This is a spontaneous report from a contactable consumer or other Non-health care professional.  A 57-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number: 1EL9261, expiry date: not reported) via an unspecified route of administration in the region of left arm on 25Jan2021 at 12:00 as SINGLE DOSE for covid-19 immunization. Medical history included covid-19 from an unknown date and unknown if ongoing. Allergies to medications, food, or other products was reported as unknown. The patient had her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number: EL0142 expiry date: not reported) via an unspecified route of administration in the region of left arm on 04Jan2021 at 12:00 as SINGLE DOSE for covid-19 immunization. Patient stated that the technician who administered told her that the first dose was 0.4 and second dose administered was stronger (0.7). The reported finds this odd as both doses should be identical. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. List of any other medications the patient received within 2 weeks of vaccination was reported as unknown. Patient was not pregnant at the time of vaccination. Patients concomitant medications were not reported. On 25JAN2021, the patient experienced high fever, achy, hard to stand up. On 25JAN2021, the patient underwent lab tests and procedures which included body temperature: 102. The treatment received for adverse events was reported as no. The outcome of the events high fever, achy and hard to stand up was reported as recovered and second dose administered was stronger (0.7) was unknown.  Follow-up attempts are completed. No further information is expected.
Employee reports Nausea, Vomiting, Diarrhea, Severe epigastric pain the evening after she took the flu vaccine earlier that morning. Symptoms subsided and she was ok by 5:00am the next morning. Is not sure it was related to vaccine but did want it reported.
Shooting pain and severe tenderness to left ear. Intermittent left eye twitching and large swelling to left axilla with pain that has not subsided despite heat/ice application.
6th nerve palsy left eye.  Could not focus eyes. No special treatment.  Started to resolve itself slowly around June1, 2022.  As of June 28, 28, 2022, I still have some difficulty focusing  when  moving  position of eyes too quickly.
Nine days after receiving the first Covid19 vaccine, I woke up with significant hearing loss along with intermittent dizziness.  The hearing loss has continued to the present time,  but the severity fluctuates.  I've had two appointments with the audiology dept of a Clinic who administered hearing tests and confirmed hearing loss in both ears.
she woke up at midnight with a headache that lasted for a week and a half; This is spontaneous report from contactable consumer. A 72-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for Injection, Batch/Lot number: Unknown) via an unspecified route of administration on an unknown date single dose (at the age of 72-year-old) and second dose around 12:30 in the afternoon for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that when she received the first dose of the vaccine (on an unspecified date) she woke up at midnight with a headache that lasted for a week and a half. The event assessed as non-serious. On an unspecified date, headache was resolved.  Information on the Lot/Batch number has been requested.
HEAD ACH,SHOULDERS ACH ,CHEST ACH, TIRED. ADVIL. NOT OVER YET
This spontaneous report as received from a licensed practical nurse refers to a 18 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 11-JUL-2016, the patient was vaccinated with the dose of GARDASIL (lot # L010596, expiration date unknown; dose and route were not reported) that had experienced an excursion. No averse reaction was reported. This is one of several reports received from the same reporter. Additional information has been requested.
A nurse reported the occurrence of joint swelling in a 48 year old female who was vaccinated with hepatitis B vaccine recombinant (Engerix-B) for prophylaxis. The vaccine provider submitted this report directly to VAERS.  The subject had no medical history, concurrent conditions, or concurrent medications.  The subject received her first injection of Engerix-B (Lot # ENG5375A2) on 03/25/03; no adverse event was reported.  She received MMRII (Merck) on 04/11/03.  On 04/25/03 at 07:30, she received her second injection of Engerix-B (Lot # ENG5375A2).  On 04/29/03 at approximately 15:00, four days after the second injection of Engerix-B, she developed swelling of her hands, knees, and ankles with no associated pain or redness. As of 05/01/03, the joint swelling had resolved.
Information has been received from a physician concerning a patient who was vaccinated with a dose of ZOSTAVAX (Merck).  The patient developed shingles after receiving the vaccine.  The patient sought unspecified medical attention.  Follow up information has been received from the physician concerning this 77 year old retired white male with prostate cancer and no history of chickenpox or recent exposure to chickenpox or herpes ZOSTER who on 28-APR-2007 (also reported as 27-APR-2007) was vaccinated SC with a first "0.5" dose of ZOSTAVAX (Merck) (lot # not reported) on the arm.  There was no illness at the time of vaccination, or rash at the site of injection or elsewhere within 42 days of vaccination.  On 29-APR-2009, the patient developed shingles on his right flank with a pain score of 7 9n a scale of 0 to 10.  Direct fluorescent antibody was not performed.  There were no photos taken and there were no specimens collected for PCR analysis.  Subsequently, the patient recovered on an unspecified date.  Additional information is not expected.
SWELLING RIGHT UPPER ARM; CHILLS; PAIN IN RIGHT AND LEFT LOWER LEGS  KNEE TO ANKLES/PAIN IN RIGHT UPPER ARM; HEADACHES; EXTREME FATIGUE; SWEATING; LOSS OF APPETITE; BRAIN FOG; SEVERE STOMACH PAIN; DIARRHEA; COUGH; This spontaneous report received from a patient concerned a 63 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included borderline diabetes, without medication, abstains from alcohol, and cigarette smoker, and other pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On JUN-2020, Laboratory data included: PCR (NR: not provided) NEGATIVE. On 02-APR-2021, the subject experienced cough. On 05-APR-2021, the subject experienced sweating. On 05-APR-2021, the subject experienced loss of appetite. On 05-APR-2021, the subject experienced brain fog. On 05-APR-2021, the subject experienced severe stomach pain. On 05-APR-2021, the subject experienced diarrhea. On 05-APR-2021, the subject experienced chills. On 05-APR-2021, the subject experienced pain in right and left lower legs knee to ankles/pain in right upper arm. On 05-APR-2021, the subject experienced headaches. On 05-APR-2021, the subject experienced extreme fatigue. On 07-APR-2021, the subject experienced swelling right upper arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from severe stomach pain, and diarrhea on 05-APR-2021, had not recovered from cough, headaches, sweating, pain in right and left lower legs knee to ankles/pain in right upper arm, extreme fatigue, loss of appetite, brain fog, and swelling right upper arm, and the outcome of chills was not reported. This report was non-serious.
Patient expecrienced pain in arm for 36 hours after injection. It recurred one week later.
Patient came in with swollen, red, warm lump at injection site that spread down the arm slightly. Patient stated that her arm was sore and that these symptoms occurred this morning when she woke up. No other systemic signs were noted by the patient. The redness has not spread anymore.
Severe headache (8/10 pain scale) on left side of head only; with nausea; telephone consult with healthcare provider; treat with acetaminophen at home with instructions to visit E.R. if not resolving.  1st dose Acetaminophen 650 mg x 2 tablets temporarily resolved pain; 2nd dose x 2 tablets  [8-1/2 hrs later) fully resolved pain. Fatigue present 48 hours was not a concern.
No additional AEs; Caller reported expired dose of RECOMBIVAX was administered; This spontaneous report was received from Other Health Professional and refers to a patient of unknown age and gender. Information regarding the patient's concomitant therapies, concurrent conditions, medical history and historical drugs was not provided.  On 25-JAN-2023, the patient was vaccinated with hepatitis b vaccine (recombinant) (RECOMBIVAX HB) intramuscular injection, 0.5 milliliter, lot #U019135, expiration date: 22-NOV-2022 (Expired product administered), administered intramuscularly for prophylaxis (strength was not provided).  No additional adverse event was reported.  This is one of several cases from the same reporter.; Sender's Comments:  US-009507513-2302USA008323: US-009507513-2302USA008440: US-009507513-2302USA008328: US-009507513-2302USA008308: US-009507513-2302USA008289: